1. First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers. Issue 1 (17th June 2020) Authors: Hong, David S; Parikh, Aparna; Shapiro, Geoffrey I; Varga, Andrea; Naing, Aung; Meric-Bernstam, Funda; Ataman, Özlem; Reyderman, Larisa; Binder, Terri A; Ren, Min; Liu, Mingjie; Dayal, Satish; Siu, Amy Y; Sachdev, Pallavi; Xu, Lucy; Bhagawati-Prasad, Vijay; Tchakov, Ilian; Ooi, Chean Eng; Bao, Xi... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗